CYP19A1 and endometriosis: Clinically, the potential advantages for puerarin to treat endometriosis are as follows; first, puerarin is able to bind to ER-alpha and ER-beta [9], it can suppress P450arom activity as aromatase inhibitors in endometriosis treatment, and it may be applicable as an adjuvant to the current medical treatments.